SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Incyte (INCY)
INCY 104.46-1.1%Nov 28 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Cytokine1 who wrote (526)11/10/1997 12:26:00 PM
From: Rocketman  Read Replies (2) of 3202
 
Chemical & Engineering News (11/3/97, pg. 9) did a medium size news piece on the
Monsanto Genomics deals and mentions RE: the INCY Monsanto deal that:

"Although the multiyear partnership is the broadest and largest financial commitment
Incyte has secured to date, monetary terms have not been made public."

I sure like the sound of that as some of their prior deals have been quite large, and
virtually every deal is at least 8 figures. Thus, this one is either high 8 figures, or could
even possibly be a 9 figure deal. YOW!!!!

Also, INCY is proceeding with the construction from the ground up of a 95,000 sq. ft
building directly next to the existing headquarters in the Stanford Research Park, so
close to the existing building that you could hit it with a rock - the INCYTE Campus
grows on...... Among other things, it will be the new corporate headquarters too. They
are doing the sardine thing in their exising spaces. Lease with Stanford has been signed,
design is under way, and the contractor has been chosen. Not sure on completion
target date, but as per INCY tradition, you can bet that you can't build the space fast
enough to keep up with the growth.

Rman
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext